What is BICO Group AB (publ) (CLLKF)?

BICO Group AB (publ) (CLLKF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of CLLKF?

The current price of CLLKF is $2.40. Prices are updated in real time on Stocks360.

What is CLLKF's price-to-earnings (PE) ratio?

CLLKF's trailing twelve-month PE ratio is -2.04, based on current price and earnings per share data available on Stocks360.

What is CLLKF's market capitalization?

CLLKF's market capitalization is $165,779,748.00, placing it in the small-cap tier.

BICO Group AB (publ) (CLLKF)

Stock analysis · OTC · Healthcare · Medical - Devices

$2.40

Market Cap

$165.78M

PE (TTM)

-2.04

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.56

Day Range

$2.40 – $2.40

52-wk Range

$1.52 – $2.56

Avg Volume

N/A

Volume

428.00

BICO Group AB (publ) (CLLKF) is a publicly traded company in the Healthcare sector. Latest price: $2.40. Market cap $165.78M. Trailing PE -2.04. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-29 · $2.33 2026-10-26 · $2.40 (+3.00%)

Earnings

Most Recent

Aug 19, 2026

EPS $-0.05 vs est. $-0.07

Beat by $0.02

Next Earnings

Nov 11, 2026

EPS estimate $0.09

Proprietary Signals

Signal snapshot temporarily unavailable.

About BICO Group AB (publ)

BICO Group AB (publ) is a global bio-convergence enterprise, conducting operations across North America, Europe, Asia, and other international markets. Its business is structured into two main divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions segment delivers a range of advanced equipment, including 3D bioprinters, hybrid microscopy systems, single-cell dispensing instruments, and liquid handling devices. This division also supplies essential consumables such as bioinks, reagents, microscope lenses, software, printheads, and even 3D reconstructed human tissues, particularly for applications in regulatory testing. Furthermore, Laboratory Solutions offers specialized services like 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology, primarily serving pharmaceutical and biotechnology companies. Conversely, the Bioautomation segment caters to industrial customers with products focused on precision dispensing and innovative biosensor technology. It also provides sophisticated diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. Overall, BICO Group's offerings include comprehensive solutions…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-2.04×
P/S (TTM)	1.11×
P/B	1.09×
PEG	0.02×
P/FCF (TTM)	-283.91×
EV / EBITDA	-1.24×
EV / Sales	0.87×
Earnings Yield	-49.03%
Free Cash Flow Yield	-0.35%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.31B
Revenue (TTM)	$1.50B
Net Income (TTM)	-$821.36M
Free Cash Flow (TTM)	$97.40M
Net Debt	-$361.20M
Working Capital	$698.10M
Gross Margin	45.61%
Operating Margin	-11.37%
Net Margin	-55.79%
Return on Equity	-49.84%
Return on Invested Capital	-7.12%